Cytotoxicity and anticancer activity of macromolecular prodrugs of 5-fluorouracil

Journal of Bioactive and Compatible Polymers

Volumn 12, Issue 4, 1997, Pages 265-281

  Nichifor, Marieta ^a   Schacht, Etienne H ^a   Seymour, Leonard W ^b   Anderson, Dave ^b   Shoaibi, Mahmood ^b  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DOSAGE; MACROMOLECULES; MOLECULAR STRUCTURE; ONCOLOGY; POLYETHYLENE GLYCOLS; POLYPEPTIDES; SYNTHESIS (CHEMICAL); TOXICITY;

CYTOTOXICITY; FLUOROURACIL;

DRUG PRODUCTS;

ANTINEOPLASTIC AGENT; DEXTRAN; DRUG CARRIER; FLUOROURACIL; FLUOROURACIL DERIVATIVE; GLYCINE ETHYL ESTER; MACROGOL; PRODRUG; TETRAPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CARBOXY TERMINAL SEQUENCE; CARCINOMA CELL; CHEMICAL STRUCTURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG HYDROLYSIS; DRUG RELEASE; DRUG SYNTHESIS; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MACROMOLECULE; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION; SURVIVAL TIME;

ANIMALIA; MURINAE;

EID: 0031254948     PISSN: 08839115     EISSN: None     Source Type: Journal    
DOI: 10.1177/088391159701200401     Document Type: Article

References (21)

1. Bundgaard H., "The double prodrug concept and its applications." Adv. Drug. Deliv. Rev. 3:39-65, 1989.
2. Ringsdorf H., "Structure and properties of pharmacologically active polymers." J. Polymer Sci. Symposia 51:135-, 1975.
3. Sesaki H., Takakura Y. and Hashida M., "Soluble macromolecular carriers for the delivery of antitumor drugs." Adv. Drug Deliv. Rev. 3:247-, 1989.
4. Calabresi P. and Parks Jr. R.E., "Antimetabolites." In: Pharmacological Basis of Therapeutics (Eds., Goodman L.S., Sarkar F.H., Crissman J.D. and Fridman R.) pp. 1268-1276, McMillan New York, 1985.
5. Akashi M. and Takemoto K., "New aspects of polymer drugs." Adv. Polymer Sci. 97:108-146, 1990.
6. Ouchi T., Fujino A., Tanaka K. and Banba Y., "Synthesis and antitumor activity of conjugates of poly(α-malic acid) and 5-fluorouracil bound via ester, amide or carbamoyl bonds." J. Controlled Release 12:143-153, 1990.
7. Ouchi T., Hagihara Y., Takashi K., Takano Y. and Igarashi I., "Synthesis and antitumor activity of poly(ethylene glycol)s linked to 5-fluorouracil via urethane or urea bonds," Drug Design Discovery 9:93-105, 1992.
8. Ouchi T., Banba T., Matsumoto T., Suzuki S. and Suzuki M., "Synthesis and antitumor activity of conjugates of 5-fluorouracil and chito-oligosaccharides involving a hexamethylene spacer group and carbamoyl bonds." Drug Design Delivery 6:281-287, 1990.
9. Nichifor M., Coessens V. and Schacht E. H., "Macromolecular prodrugs of 5-fluorouracil. 1. Synthesis and hydrolytic stability." J. Bioact. Comp. Polymers 10:199-222, 1995.
10. Nichifor M., Seymour L. W. and Schacht E. H., "Macromolecular prodrugs of 5-fluorouracil. 2. Enzymatic degradation." J. Controlled Release 39:79-92, 1996.
11. Choksakulnimitr S., Masuda S., Tokuda H., Takakura Y. and Hashida M., "In vitro cytotoxicity of macromolecules in different cell culture systems." J. Controlled Release 34:233-241, 1995.
12. Katre N. V., "The conjugation of proteins with polyethylene glycol and other polymers." Adv. Drug Deliv. Rev. 10:91-114, 1993.
13. Nakajima N. and Ikada Y., "Effects of concentration, molecular weight, and exposure time of poly(ethylene glycol) on cell fusion." Polymer J. 27:211-219, 1995.
14. Milburn Jessup J., "Cathepsin B and other proteases in human colorectal carcinoma." Am. J. Patol 145:253-262, 1994.
15. Campo E., Munoz J., Miquel R., Palacin A., Cardesa A., Sloane B.F. and Emmert-Buck M.R., "Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival." Am. J. Patol 145:301-309, 1994.
16. Caliceti P., Monfardini C., Sartore L., Schiavon O., Baccichetti E, Carlassare F. and Veronese F.M., "Preparation and properties of monomethoxy poly(ethylene glycol) doxorubicin conjugates linked by an amino acid or a peptide as spacer." Il Farmaco 48:919-932, 1993.
17. Chu B.C.F. and Whiteley J.M., "High molecular weight derivatives of methotrexate as chemotherapeutic agents." Mol. Pharmacol 13:80-88, 1977.
18. Dang W., Colvin O.M., Brem H. and Saltzman W.M., "Covalent coupling of methotrexate to dextran enhances the penetration of cytotoxicity into a tissue-like matrix." Cancer Res. 54:1729-1735, 1994.
19. Seynour L.W., Duncan R., Strohalm J. and Kopecek J., "Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal and intravenous administration to rats." J. Biomed Mater. Res. 21:1341-1358, 1987.
20. Seymour L.W., "Passive tumor targeting of soluble macromolecules and drug conjugates." Crit. Rev. Therapeut. Drug Carrier Syst. 9:135-187, 1992.
21. Matsumura Y. and Maeda H. "A new concept for macromolecular therapeutics in cancer therapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS." Cancer Res. 46:6387-6393, 1986.